Skip to main content
Market intelligence
ODTXSector not reported

Odyssey Therapeutics, Inc. insider activity

In the last 90 days, 10 corporate insiders purchased $135,384,060 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$135,384,060
Corporate buyers
10
Latest transaction
May 11, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 11, 2026James G CoulterCorporate insiderOpen Market Purchase1,388,889$18.00$25,000,002
May 11, 2026Jon WinkelriedCorporate insiderOpen Market Purchase1,388,889$18.00$25,000,002
May 11, 2026Tpg Gp A LlcCorporate insiderOpen Market Purchase1,388,889$18.00$25,000,002